EWM
ATRS

Elmwood Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Elmwood Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$22K Hold
5,000
– – 0.01% 215
2021
Q1 		$21K Buy
+5,000
New +$21.7K 0.01% 215

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Elmwood Wealth Management's ATRS Position: Q2 2021 in Review

Elmwood Wealth Management held its Antares Pharma, Inc. (ATRS) position steady in Q2 2021 at 5,000 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #215.

Elmwood Wealth Management first reported a position in ATRS in Q1 2021 and has held it in 2 quarters since. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

  • Elmwood Wealth Management held 5,000 shares of Antares Pharma, Inc. worth $22K as of Q2 2021.
  • Elmwood Wealth Management left its Antares Pharma, Inc. share count unchanged in Q2 2021.
  • Antares Pharma, Inc. made up 0.01% of Elmwood Wealth Management's portfolio in Q2 2021, its #215 holding.
  • Elmwood Wealth Management first reported a position in Antares Pharma, Inc. in Q1 2021 and has held it in 2 quarters since.
  • 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Elmwood Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.